Bhushan Kharbikar, PhD, a postdoctoral fellow in the laboratories of Professors Qizhi Tang, PhD, and Tejal Desai, PhD, has been awarded a prestigious JDRF Advanced Postdoctoral Fellowship. JDRF is the leading global organization funding type 1 diabetes (T1D) research. This JDRF fellowship is designed to attract qualified and promising...
News
Kharbikar (right) standing next to his mentor, Desai (left).
Tue Apr 30, 2024
Mon Apr 1, 2024
The Preclinical Design and Clinical Translation of TB Regimens (PReDicTR) Consortium has been awarded a $30.8M grant over five years to research the most effective treatment options for future clinical testing.
Mon Mar 18, 2024
School researchers netted $36.7M from 65 grants, fueling efforts spanning drug discovery, bioengineering, pharmacokinetics, clinical pharmacy, and more.
Thu Feb 1, 2024
The first program of its kind in the United States, the MS in AICD3 will enable its graduates to gain a competitive edge for some of the most desirable jobs in the biopharmaceutical industry and in academia.
Mon Nov 27, 2023
Su Guo, PhD, will lead a new center to increase collaboration between clinical, translational, and discovery science in teaching and research.
Thu Nov 16, 2023
Students keep pace with latest innovations through experiential options and advanced degrees.
Wed Nov 1, 2023
Computational biology and protein engineering expert will focus on cultivating collaboration.
Thu Sep 21, 2023
QBI publishes breakthrough on COVID-19 variants; Nevan Krogan recognized as trailblazer.
Wed Sep 13, 2023
Dean Kathy Giacomini shares how the School’s recent breakthroughs and accomplishments are bringing our new strategic plan to life.
Fri Sep 1, 2023
Scientists have shown for the first time that kidney cells—housed in an implantable device called a bioreactor—can survive while implanted.
- Page 1
- ››